Electric Field Therapy as an Alternative Medicine in the Clinical Management of Cancer

The company Novocure has developed a viable chemotherapy alternative in the form of electric field therapy. This Novocure product has been given FDA approval for recurrent glioblastoma. However, they currently have Phase I, Phase II and Phase III clinical trials underway for a variety of other cancers. The treatment is a noninvasive monotherapy and incorporates Tumor Treating Fields to interrupt mitotic division in rapidly dividing cells with a low number of adverse effects. Dr. Palti spearheaded this product and has outreached to over 2,200 patients, allowing them to receive treatment without major lifestyle modifications.Read Complete Article at ijSciences: V4201511868 AND DOI: http://dx.doi.org/10.18483/ijSci.86